ABSTRACT
The COVID-19 pandemic has caused global declines in life expectancy; it is therefore critical to understand risk factors related to mortality and morbidity for this infectious disease. Past work indicates that certain pre-existing medical conditions, behavioral patterns, and sociodemographic factors may increase COVID-19-related negative outcomes. Left unexplored, however, is whether COVID-19 outcomes are influenced by exposure to childhood adversity. This is a notable gap given that childhood adversity is associated with lifelong physical health disparities and early mortality. We leverage data from the UK Biobank cohort (N=151,200) to investigate relations between early childhood adversity and COVID-19 mortality and morbidity. As predicted, we show that childhood adversity is associated with a higher risk of COVID-19 hospitalization and mortality, even after adjusting for potential confounding variables. Such results highlight the importance of considering early-life experiences and their impact on COVID-19 outcomes to guide public health intervention and prevention strategies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board at the University of Pittsburgh has approved of this work, under protocol STUDY22080014. The Institutional Review Board determined that the proposed activity is not research involving human subjects as defined by DHHS and FDA regulations, given that it was using secondary research with previously collected, de-identified data.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data are available from the UB Biobank. This resource is available to scientists from the UK and outside, whether they work in the public or private sector, for industry, academia or a charity, subject to verification that the research is health-related and in the public interest.